- Home
- » CME / CE Programs
- » Biologic Bulletins
- » Addressing Cardiovascular Comorbidities in Psoriasis Patients
Addressing Cardiovascular Comorbidities in Psoriasis Patients
Release date: October 2009
Expiration date: October 31, 2010
Estimated time to complete activity: 1 hour
No longer available for CME credit
Co-provided by Curatio CME Institute and Dermatology Nurses' Association
Support for this activity has been provided through educational grants from Amgen and Genentech.
Activity Overview
The systemic inflammatory nature of psoriasis and its association with cardiovascular comorbidities are important considerations for the management of patients with psoriasis. Moreover, the recognition that younger patients with more severe disease are at increased risk for poor cardiovascular outcomes warrants early detection of patients who are most at risk for cardiovascular disease. This Biologic Bulletin examines the risk for cardiovascular disease in patients with psoriasis, the mechanisms that contribute to cardiovascular comorbidites, and the effect that psoriasis treatment has on cardiovascular outcomes.
Target Audience
This activity has been designed to meet the educational needs of dermatologists, dermatology residents and fellows, dermatology nurses, nurse practitioners, and physician assistants who manage patients with moderate to severe psoriasis.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize the clinical effect of psoriasis on the development of cardiovascular comorbidities
- Describe mechanisms of endothelial damage and increased cardiovascular risk in patients with psoriasis
- Identify patients with psoriasis who may be at greatest risk for developing cardiovascular comorbidities
- Evaluate evidence regarding biologic agents and cardiovascular risk
Editors
Bruce Strober, MD, PhD
Assistant Professor and Associate Director
Dermatopharmacology Unit
New York University School of Medicine
New York, New York
Melodie Young, MSN, RN, A/GNP-C
Nurse Practitioner
Modern Dermatology, a Baylor-Health Texas Affiliate
Adjunct Clinical Instructor
The University of Texas Arlington, Graduate School of Nursing
Dallas, Texas
Accreditation
Physician
Curatio CME Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Curatio CME Institute designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nursing
The Dermatology Nurses’ Association (DNA) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.
Provider approved by the California Board of Registered Nursing, Provider Number CEP5708.
Accreditation refers to educational content only.
Method of Participation
There are no fees for participating in this CME/CE activity. To receive credit during the period October 2009 to October 31, 2010, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the posttest and activity evaluation form. Participants who successfully complete the activity can download a CME/CE certificate from this site.
Media
A downloadable/printed newsletter and the Internet were selected as the instructional formats to accommodate the learning preferences of a significant portion of our target audience.
Disclosure
In accordance with the ACCME Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below.
Bruce Strober, MD, PhD, has disclosed the following relevant financial relationships:
| Advisor/Consultant/Speaker | Abbott, Amgen, Centocor Ortho Biotech |
Melodie Young, MSN, RN, A/GNP-C, has disclosed the following relevant financial relationships:
| Advisor | Abbott, Centocor Ortho Biotech |
| Speaker | Abbott, Amgen, Astellas, Centocor Ortho Biotech |
This newsletter may include discussions of the unlabeled or investigational use of commercial products and/or the use of unapproved investigational agents.
This activity was peer reviewed by a third party for potential bias; no bias was found.
Curatio CME Institute
Shari J. Dermer, PhD, Medical Director, has disclosed no relevant financial relationships.
Adam J. Perahia, MD, Medical Writer, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Managing Editor, has disclosed no relevant financial relationships.
Derek Warnick, CME Director, has disclosed no relevant financial relationships.
Disclaimer
The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute, Amgen, and Genentech, Inc. do not recommend the use of any agent outside the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute, Amgen, or Genentech, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
| Generic Name | Trade Name | Approved Use (if any) | Unapproved/Investigational Use |
| Simvastatin | Zocor | Adjunctive therapy to diet to:
|
|
Hardware/Software Requirements
- JavaScript enabled browser
- Adobe Flash Player plugin v.8.0+
Contact Information
PsoriasisTx.com
100 Campbell Boulevard
Suite 103
Exton, PA 19341
editor@psoriasistx.com
Policy on Privacy and Confidentiality
Curatio CME Institute makes every effort to protect the privacy of PsoriasisTx.com users; user information is used only to maintain records as required by the American Medical Association (AMA) and the ACCME.
Curatio CME Institute does not require individuals to register to use PsoriasisTx.com; registration is only required for physicians, health care professionals, and other users to participate in and receive CME/CE credit for accredited educational programs hosted on PsoriasisTx.com
Curatio CME Institute is required by the AMA and the ACCME (and occasionally by other accrediting organizations) to collect user information that will allow Curatio CME Institute to issue a CME/CE certificate. Curatio CME Institute is required to keep this information on file for up to 6 years. The information is stored in a secure database and used only to verify individual participation in a CME/CE activity and to reissue a certificate if a user's original certificate is lost or misplaced.
Information gathered through PsoriasisTx.com will not be released to any other company or organization for any purpose; this information remains confidential.
Curatio CME Institute uses Web site tracking software to determine how PsoriasisTx.com is used. This information helps Curatio CME Insitute determine the best strategies for improving PsoriasisTx.com and better meeting the needs of its users. This software does not identify individual users.
If you have any questions about PsoriasisTx.com or any Curatio CME Institute policies, you may contact us at info@psoriasistx.com.
Thank you for using PsoriasisTx.com.
